Altimmune to Present at the 2021 Jefferies Virtual Healthcare Conference
GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the 2021 Jefferies Virtual Healthcare Conference, being held June 1 - 4, 2021.
Details on the Jefferies fireside chat presentation are as follows:
Title: | 2021 Jefferies Virtual Healthcare Conference | ||
Presenters: | Vipin Garg, Ph.D., Chief Executive Officer | ||
Scot Roberts, Ph.D., Chief Scientific Officer | |||
Scott Harris, M.D., Chief Medical Officer | |||
Date/Time: | Wednesday, June 2, 2021 at 11:30 am ET |
A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.
About Altimmune
Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.
Investor & Media Contacts: | ||
Will Brown | Stacey Jurchison | |
Chief Financial Officer | Sr. Dir, Investor Relations | |
Phone: 240-654-1450 | Phone : 410-474-8200 | |
